Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
作者信息
Hatton Jessica N, Sargen Michael R, Frone Megan N, de Andrade Kelvin C, Savage Sharon A, Khincha Payal P
机构信息
Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, USA.
出版信息
J Invest Dermatol. 2022 Sep;142(9):2534-2537.e1. doi: 10.1016/j.jid.2022.02.004. Epub 2022 Feb 17.
Abstract
摘要
相似文献
1
Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
J Invest Dermatol. 2022 Sep;142(9):2534-2537.e1. doi: 10.1016/j.jid.2022.02.004. Epub 2022 Feb 17.
2
Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome.
Fam Cancer. 2023 Jul;22(3):319-321. doi: 10.1007/s10689-022-00326-9. Epub 2023 Jan 11.
3
Is Li-Fraumeni syndrome really much more common?
Hum Mutat. 2017 Dec;38(12):1619. doi: 10.1002/humu.23342.
4
Cancer surveillance for individuals with Li-Fraumeni syndrome.
Eur J Hum Genet. 2020 Nov;28(11):1481-1482. doi: 10.1038/s41431-020-00709-5. Epub 2020 Aug 19.
5
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398.
6
Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1403-6.
7
Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
J Steroid Biochem Mol Biol. 2019 Jun;190:250-255. doi: 10.1016/j.jsbmb.2019.04.011. Epub 2019 Apr 8.
8
Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes.
Oncologist. 2017 Sep;22(9):1084-1085. doi: 10.1634/theoncologist.2017-0016. Epub 2017 Jun 7.
9
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.
Lancet Oncol. 2021 Dec;22(12):1787-1798. doi: 10.1016/S1470-2045(21)00580-5. Epub 2021 Nov 12.
10
is not a Li-Fraumeni syndrome gene: time to update public resources.
J Med Genet. 2023 Nov 27;60(12):1215-1217. doi: 10.1136/jmg-2023-109464.
引用本文的文献
1
Characterization of sarcoma topography in Li-Fraumeni syndrome.
Front Oncol. 2024 Nov 7;14:1415636. doi: 10.3389/fonc.2024.1415636. eCollection 2024.
2
Overview of familial syndromes with increased skin malignancies.
Arch Dermatol Res. 2023 May;315(4):707-727. doi: 10.1007/s00403-022-02447-8. Epub 2022 Nov 7.
本文引用的文献
1
Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome.
Fam Cancer. 2020 Oct;19(4):347-351. doi: 10.1007/s10689-020-00178-1.
2
Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families.
J Invest Dermatol. 2020 Jan;140(1):174-181.e3. doi: 10.1016/j.jid.2019.06.138. Epub 2019 Jul 18.
3
A rare case of multiple cutaneous melanomas in Li-Fraumeni syndrome: A coincidental association or a component of the syndrome?
Australas J Dermatol. 2019 Aug;60(3):e214-e216. doi: 10.1111/ajd.13012. Epub 2019 Feb 26.
4
Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature.
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e174-e175. doi: 10.1111/jdv.15430. Epub 2019 Feb 27.
5
Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene.
Am J Dermatopathol. 2018 Mar;40(3):225-227. doi: 10.1097/DAD.0000000000000919.
6
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.
7
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.
8
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
J Clin Oncol. 2015 Jul 20;33(21):2345-52. doi: 10.1200/JCO.2014.59.5728. Epub 2015 May 26.
9
Atypical fibroxanthoma arising in a young patient with Li-Fraumeni syndrome.
J Cutan Pathol. 2014 Mar;41(3):303-7. doi: 10.1111/cup.12274. Epub 2013 Dec 24.
10
Li-fraumeni syndrome.
Genes Cancer. 2011 Apr;2(4):475-84. doi: 10.1177/1947601911413466.
Zotero 插件